WallStreetZenWallStreetZen

NASDAQ: INAB
In8bio Inc Stock Forecast, Predictions & Price Target

Analyst price target for INAB

Based on 3 analysts offering 12 month price targets for In8bio Inc.
Min Forecast
$5.00+313.22%
Avg Forecast
$8.83+630%
Max Forecast
$14.00+1,057.02%

Should I buy or sell INAB stock?

Based on 3 analysts offering ratings for In8bio Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their INAB stock forecasts and price targets.

INAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-18
lockedlocked$00.00+00.00%2024-03-15
lockedlocked$00.00+00.00%2024-03-13

1 of 1

Forecast return on equity

Is INAB forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is INAB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

INAB revenue forecast

What is INAB's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$27.6M
Avg 2 year Forecast
$143.0M
Avg 3 year Forecast
$232.4M

INAB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INAB$1.21$8.83+630.00%Strong Buy
QTTB$16.17N/AN/A
MLEC$1.38$6.00+334.78%Strong Buy
ELDN$2.13$13.00+510.33%Buy
NXTC$1.94$6.00+210.08%Buy

In8bio Stock Forecast FAQ

Is In8bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: INAB) stock is to Strong Buy INAB stock.

Out of 3 analysts, 2 (66.67%) are recommending INAB as a Strong Buy, 1 (33.33%) are recommending INAB as a Buy, 0 (0%) are recommending INAB as a Hold, 0 (0%) are recommending INAB as a Sell, and 0 (0%) are recommending INAB as a Strong Sell.

If you're new to stock investing, here's how to buy In8bio stock.

What is INAB's revenue growth forecast for 2025-2027?

(NASDAQ: INAB) In8bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

In8bio's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast INAB's revenue for 2025 to be $1,194,730,170, with the lowest INAB revenue forecast at $1,194,730,170, and the highest INAB revenue forecast at $1,194,730,170. On average, 1 Wall Street analysts forecast INAB's revenue for 2026 to be $6,190,087,475, with the lowest INAB revenue forecast at $6,190,087,475, and the highest INAB revenue forecast at $6,190,087,475.

In 2027, INAB is forecast to generate $10,061,705,823 in revenue, with the lowest revenue forecast at $10,061,705,823 and the highest revenue forecast at $10,061,705,823.

What is INAB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: INAB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is INAB's Price Target?

According to 3 Wall Street analysts that have issued a 1 year INAB price target, the average INAB price target is $8.83, with the highest INAB stock price forecast at $14.00 and the lowest INAB stock price forecast at $5.00.

On average, Wall Street analysts predict that In8bio's share price could reach $8.83 by Mar 18, 2025. The average In8bio stock price prediction forecasts a potential upside of 630% from the current INAB share price of $1.21.

What is INAB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: INAB) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.